Source comparison
TB-500 Per Day vs Per Week: Dosing Comparison
Daily (1mg/day) 7mg 7 injections/week Excessive peaks Unnecessary buildup No published protocols 3x weekly (2.5mg per dose) 7.5mg 3 injections/week Stable Therapeutic range Standard loading phase 2x weekly (2.5mg per dose) 5mg 2 injections/week Common loading
This comparison does not assign a generated winner or score.
- Daily (1mg/day)
- 7mg
- 7 injections/week
- Excessive peaks
- Unnecessary buildup
- No published protocols
- 3x weekly (2.5mg per dose)
- 7.5mg
- 3 injections/week
- Stable
- Therapeutic range
- Standard loading phase
- 2x weekly (2.5mg per dose)
- 5mg
- 2 injections/week
- Common loading protocol
- Weekly (5mg single dose)
- 1 injection/week
- Fluctuating
- Adequate
- Maintenance phase
- 2x weekly (1.5mg per dose)
- 3mg
- Maintenance level
- Standard maintenance
- Clinical Insight
- The half-life of thymosin beta-4 makes injection frequency a function of pharmacokinetics, not convenience. Splitting weekly totals into 2–3 doses maintains plasma stability without the tissue saturation that daily dosing would create.